Sagdic MF, Tunc E, Kulturoglu MO, Yildirim OA, Dogan L. HER2 IHC score as a predictor of pathologic complete response in HER2-positive breast cancer after neoadjuvant therapy. Ann Med Res . 2026;33(8):369-374. Accessed September 5, 2026. http://www.annalsmedres.org/index.php/aomr/article/view/4937